지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2021.11
- 수록면
- 451 - 455 (5page)
이용수
초록· 키워드
오류제보하기
Supported by the expanding indications for neoadjuvant therapy (NAT) for advanced pancreatic cancer (PC), the concept of resectability has evolved from being mostly based on the anatomical tumor extent to considering the biological and conditional factors relevant to prognosis. Therefore, it is more reasonable to define the “criteria for surgical resection” instead of using the “(technical) resectability criteria.” NAT has been used in resectable PCs (RPC) with a high risk of early systemic recurrence, as predicted by various biological or anatomical markers. Moreover, the indications for NAT followed by conversion surgery or adjuvant surgery for borderline resectable or locally advanced PC (LAPC) are gradually expanding. Therefore, it is important to define the RPC group that will benefit from NAT and the LAPC group that will benefit from post-NAT surgery. At diagnosis, population-based approaches, such as prognostic stratification and staging systems and personalized outcome-based approaches using prognostic prediction models can be used to determine the criteria for treatment options. Standardized indications for conversion surgery are needed for patients who are initially treated with NAT. In addition to imaging-based morphological criteria, biological criteria, including CA19-9, and various metabolic criteria can be used to establish predicted outcome-based criteria. Multicenter collaboration is required to develop a large database with standardized data collection for various biomarkers and response data after NAT to establish more accurate outcome prediction models to define the new resectability criteria.
목차
INTRODUCTION
RESECTABILITY DETERMINATION AT DIAGNOSIS
RESECTABILITY DETERMINATION AFTER NEOADJUVANT THERAPY
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
Recent treatment patterns and survival outcomes in pancreatic cancer according to clinical stage based on single-center large-cohort data
Annals of Hepato-Biliary-Pancreatic Surgery
2018 .11
-
Risk Stratification of Pancreatic Ductal Adenocarcinoma Patients Undergoing Curative-Intent Surgery after Neoadjuvant Therapy
Cancer Research and Treatment
2024 .01
-
Assessment of Neoadjuvant Treatment Response Using Automated Breast Ultrasound in Breast Cancer
Journal of Breast Cancer
2022 .08
-
Pathologic Evaluation of Breast Cancer after Neoadjuvant Therapy
Journal of Pathology and Translational Medicine
2016 .01
-
The impact of nucleic acid testing as a blood donor screening method in transfusion-associated hepatitis C among children with bleeding disorders in Indonesia: a single-center experience
Blood Research
2022 .06
-
The Expansion of Criteria for Resectability of Colorectal Liver Metastasis : How Far Can We Go?
대한외과학회 학술대회 초록집
2019 .10
-
Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .05
-
Current status of neoadjuvant therapy for pancreas cancer
대한임상종양학회 학술대회지
2021 .06
-
The role of down staging treatment in the management of locally advanced intrahepatic cholangiocarcinoma: Review of literature and pooled analysis
Annals of Hepato-Biliary-Pancreatic Surgery
2020 .02
-
Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2022 .01
-
국소 진행성 췌장암에서의 내시경적 국소 치료
대한췌담도학회지
2020 .01
-
The Role of Neoadjuvant Treatment in Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2019 .10
-
The change of clinical stage after neoadjuvant chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
-
Pancreatectomy following neoadjuvant treatment can improve oncologic outcome in high metabolic active resectable pancreatic cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
-
Great Debates: Which is the Best? Resectable pancreatic cancer: Neoadjuvant treatment first
대한임상종양학회 학술대회지
2019 .02
-
Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2023 .03
-
Evaluation of Response to Preoperative Chemotherapy Versus Surgery Alone in Gastroesophageal Cancer: Tumor Resectability, Pathologic Results and Post-Operative Complications
Asian Pacific journal of cancer prevention : APJCP
2016 .01
-
Clinical significance of defining borderline resectable pancreatic cancer
한국간담췌외과학회 학술대회지
2017 .03
-
Development of Deep Learning Prognostic Model for Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2021 .11
-
Contemporary management of borderline resectable pancreatic ductal adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2019 .05
이 논문의 저자 정보
최근 본 자료
댓글(0)
0